on MEDINCELL (EPA:MEDCL)
Mirova crosses a threshold at MEDINCELL
On February 17, 2026, MEDINCELL announced that Mirova, through funds it manages, has fallen below the 5% threshold of voting rights within the company.
On February 11, 2026, Mirova held 2,146,364 MEDINCELL shares, representing 6.44% of the total share capital but only 4.89% of the voting rights. This increase was due to a sale of shares on the market.
MEDINCELL is listed on Euronext Paris, with a total capital of 33,345,782 shares representing 43,873,721 voting rights.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all MEDINCELL news